Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 5479s-5481s, October 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mueller, N. E.
Right arrow Articles by Evans, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mueller, N. E.
Right arrow Articles by Evans, A.

Viruses Other than HIV and Non-Hodgkin's Lymphoma1

Nancy E. Mueller, Alejandro Mohar and Alfred Evans

Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115 [N. E. M.]; Department of Epidemiology, Instituto Nacional de Cancerologia, Avenue Sn. Fernando No. 22, Tiaipan, Mexico, D.F., C.P. 14000 [A. M.]; and Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06510 [A. E.]

There are several viral infections which are known to cause lymphoma among animals; all establish latency in lymphoid cells. The human T-lymphotropic virus type I is a human virus which causes lymphomas among a subset of carriers. However, this virus is very restricted in its distribution and as such, is unlikely to play a role in the increase of non-Hodgkin's lymphoma (NHL). A highly prevalent infection, the Epstein-Barr virus (EBV) is known to play a role in the etiology of NHL among persons with acquired or inherited immune suppression. However, whether it is involved with "spontaneous" NHL is unknown. We have found evidence that among a group of 104 NHL patients with blood samples taken several years before diagnosis, there was an alteration in the antibody profile against the EBV which is quite similar to that seen for immune-suppressed patients prior to their diagnosis. This pattern is most evident in the oldest patients. This suggests that there may be an age-related subclinical immune suppression leading to chronic activation of EBV. If a viral infection is a major factor in the recent increase in NHL in the world, then we should consider the role of immune-suppressive exposures which have become widespread in recent decades.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.